Internal Medicine, Hematology · Cranston, RI
NPI
1871577999
Since 2005
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1220 Pontiac Ave, Suite 101
Cranston, RI, 02920
Phone (401) 943-4660
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
673 services
Medicare patients, 2024
233
Average age 76
Drug cost, 2024
$5.9M
1,560 prescriptions
Company payments, 2025
$50.02
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter B Rintels was code 99214 (office e&m - established), 387 times for 129 patients. In total Peter B Rintels billed 673 services in 10 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 387 | 129 | $72.09 | $28K |
| 99213 Office E&M - Established | Office | 189 | 130 | $46.83 | $8,850 |
| 99215 Office E&M - Established | Office | 31 | 20 | $103.14 | $3,197 |
| 99205 Office E&M - New | Office | 24 | 24 | $136.90 | $3,286 |
| 99204 Office E&M - New | Office | 15 | 15 | $83.77 | $1,257 |
By year: 2022 $42K for 622 services; 2023 $36K for 537 services; 2024 $47K for 673 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter B Rintels prescribed most often to Medicare patients was Hydroxyurea, with 125 prescriptions and refills. In total Peter B Rintels wrote 1,560 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 125 | 281 | 31 | $3,078 |
| Eliquis Apixaban | 118 | 170 | 26 | $93K |
| Xarelto Rivaroxaban | 117 | 149 | 22 | $81K |
| Acyclovir Generic | 91 | 148 | 20 | $1,398 |
| Prednisone Generic | 89 | 95 | 21 | $548 |
| Venclexta Venetoclax | 81 | 81 | Under 11 | $877K |
| Jakafi Ruxolitinib Phosphate | 64 | 64 | Under 11 | $1.1M |
| Lenalidomide Generic | 61 | 61 | 12 | $789K |
| Oxycodone Hcl Generic | 56 | 56 | Under 11 | $404 |
| Brukinsa Zanubrutinib | 50 | 50 | Under 11 | $634K |
| Ondansetron Hcl Generic | 48 | 48 | 19 | $550 |
| Warfarin Sodium Generic | 45 | 71 | Under 11 | $353 |
| Celecoxib Generic | 36 | 37 | Under 11 | $516 |
| Allopurinol Generic | 36 | 54 | 13 | $397 |
| Calquence Acalabrutinib Maleate | 35 | 35 | Under 11 | $448K |
Brand drugs: - claims; generic drugs: 940 claims; opioid claims: 59.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter B Rintels $50.02 ($50.02 in general payments such as food, travel and fees) from 2 companies. The largest payer was Eisai Inc. with $27.87.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.